Blockchain Registration Transaction Record

New Protein Target Could Boost Glioblastoma Therapy

Scientists find a protein target that could make deadly glioblastoma more treatable, offering hope for combination therapies and new drug development. Learn more.

This discovery matters because glioblastoma is notoriously difficult to treat, with a median survival of only 12-15 months. Identifying a protein that can be targeted to make the cancer more vulnerable could lead to more effective combination therapies, potentially extending the lives of patients. For the biotech industry, this opens up opportunities for developing new drugs or repurposing existing ones, which could have significant commercial and medical implications.